CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for WeLeader Biomedical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

WeLeader Biomedical Co Ltd
19F-1/2
No.80, Minzu 1st Road, Sanmin District
Phone: +886 73800773p:+886 73800773 KAOHSIUNG, 807  Taiwan Ticker: 77137713

Business Summary
WeLeader Biomedical Co Ltd is a Taiwan-based company mainly engaged in the agency and trading business of in vitro diagnostic instruments and reagent-related products, as well as the provision of medical testing-related services. The Company is engaged in providing distribution, after-sales and maintenance services of laboratory reagents, consumables, instruments and equipment, construction planning of medical testing laboratory sites, equipment procurement, operational coaching and other ancillary services, as well as human resources construction and training, operational coaching, and digital medical examination platforms. Products are mainly sold domestically.
(Source: N-30D)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023-----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Corporate Executive, Director ZhongcaiShe 6/11/2024 6/11/2024

General Information
Outstanding Shares: 41,579,000 (As of 9/30/2024)
Shareholders: 303
Stock Exchange: TPO
Fax Number: +886 73800751


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024